These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7252978)

  • 1. Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.
    Anderson K; Kuruvilla A; Uretsky N; Miller DD
    J Med Chem; 1981 Jun; 24(6):683-7. PubMed ID: 7252978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic agonists: comparative actions of amine and sulfonium analogues of dopamine.
    Hamada A; Chang YA; Uretsky N; Miller DD
    J Med Chem; 1984 May; 27(5):675-80. PubMed ID: 6143827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine agonists: effects of charged and uncharged analogues of dopamine.
    Chang YA; Ares J; Anderson K; Sabol B; Wallace RA; Farooqui T; Uretsky N; Miller DD
    J Med Chem; 1987 Jan; 30(1):214-8. PubMed ID: 3806598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
    Sabol B; Boldry R; Farooqui T; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1987 May; 36(10):1679-85. PubMed ID: 3109428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.
    Turowski B; Szkrybalo M; Anderson K; Miller D; Uretsky N
    Biochem Pharmacol; 1984 Aug; 33(15):2371-6. PubMed ID: 6466358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.
    Wallace RA; Wallace L; Harrold M; Miller D; Uretsky NJ
    Biochem Pharmacol; 1989 Jun; 38(12):2019-25. PubMed ID: 2525907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine.
    Woodruff GN; Watling KJ; Andrews CD; Poat JA; McDermed JD
    J Pharm Pharmacol; 1977 Jul; 29(7):422-7. PubMed ID: 19581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dopamine amides with essential or fundamental fatty acids. Synthesis and pharmacological study].
    Kolocouris N; Foscolos GB; Fytas G; Sakellariou A; Raftopoulos C; Papadopoulou-Daïfoti Z; Vamvakidès A
    Ann Pharm Fr; 1991; 49(2):99-110. PubMed ID: 1681774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine.
    St-Pierre JA; Bédard PJ
    Eur J Pharmacol; 1995 Jan; 272(2-3):123-9. PubMed ID: 7713155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones.
    Jaen JC; Wise LD; Heffner TG; Pugsley TA; Meltzer LT
    J Med Chem; 1991 Jan; 34(1):248-56. PubMed ID: 1671416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activity of amantadine: effect of N-alkyl substitution.
    Dunn JP; Henkel JG; Gianutsos G
    J Pharm Pharmacol; 1986 May; 38(5):353-6. PubMed ID: 2872310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troponoids. 7. Chemistry and dopamine agonist activity of ciladopa and related aralkyltroponylpiperazines.
    Bagli J; Bogri T; Voith K; Lee D
    J Med Chem; 1986 Feb; 29(2):186-93. PubMed ID: 3950903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
    van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
    J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J; De Vries JB; Tepper PG; Krause DN; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Mar; 147(2):249-58. PubMed ID: 3130270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
    Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological actions of N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine.
    O'Donnell JP; Azzaro AJ; Urquilla PR
    J Pharm Sci; 1980 Feb; 69(2):149-52. PubMed ID: 7359313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.